• New blood test could help avoid more than 40% of prostate biopsies, study finds

    One year ago - By News Medical

    A multi-center study that validates the clinical performance of IsoPSA - a new blood test that has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen - will be presented during a special press conference at the 13th Annual Meeting of the American Urological Association on May 18 in San Francisco.
    Read more ...